血生物标志物在没有痴呆症的基于人口的队列中识别大脑ATN异常
概括
像p-tau217这样的等离子体生物标志物显示出检测大脑粉样蛋白和变化的前景. 神经纤维光 (NfL) 可能表明神经退行,有助于在社区环境中早期发现疾病.
科学领域:
- 神经学 神经学
- 生物标志物发现发现
- 神经成像是一种神经成像.
背景情况:
- 这项研究研究了ATN (粉样蛋白,,神经退行) 框架内的血生物标志物.
- 重点是识别异常的大脑粉样β (Aβ) 定子发射断层扫描 (PET) 和tau-PET.
- 这项研究是在社会经济上处于不利地位的,以人口为基础的队列中进行的.
研究的目的:
- 评估血生物标志物的潜力,以识别异常的大脑Aβ-PET,tau-PET和神经退行.
- 评估特定的血生物标记物的诊断准确性.
主要方法:
- 包括113名社区居民,没有痴呆症的参与者 (91%的认知正常).
- 参与者接受了ATN神经成像和血生物标志物评估.
- 统计分析包括后勤回归和曲线下面积 (AUC) 计算.
主要成果:
- 血p-tau217在识别Aβ-PET状态方面表现出高精度 (AUC=0.94).
- 血p-tau181和p-tau217与tau-PET状态 (AUCs~0.70-0.74) 有关.
- 血NfL (神经纤维光) 与神经退行有关,皮质厚度表明了这一点.
结论:
- 血p-tau217是大脑Aβ和tau病理生理学的潜在生物标志物.
- 血p-tau181可能表明tau异常.
- 血NfL显示了在社区环境中检测神经退行症的潜力.
更多相关视频
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
13.9K
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
32.0K
相关概念视频
Alzheimer's Disease: Overview
323
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
323
Dementia
70
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
70
